60 Degrees Pharmaceuticals, Inc. (SXTP) climbed 19.30 percent to $3.73 during Tuesday's trading after the company released preliminary findings suggesting that the incidence of babesiosis in the U.S. may be far higher than current CDC estimates.
SXTP opened at $3.50 and touched a high of $4.42 before easing back on the Nasdaq. The stock is trading above its previous close of $3.16 on volume of 1.4 million shares, slightly below its average daily volume of 1.9 million. The stock has moved within a 52-week range of $1.41 to $36.00.
A company survey indicated that nearly 3 million Americans may have been diagnosed with the tick-borne disease, compared to the CDC's reported 1,834 cases in 2020.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.